赛托生物
(300583)
| 流通市值：22.28亿 | | | 总市值：22.71亿 |
| 流通股本：1.86亿 | | | 总股本：1.90亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 612,731,527.67 | 328,046,378.97 | 1,016,869,821.22 | 749,188,335.44 |
| 营业总成本 | 572,849,329.95 | 320,008,510.91 | 1,055,969,458.02 | 796,360,986.67 |
| 其他经营收益 | | | | |
| 营业利润 | 40,645,617.01 | 5,456,803.36 | -76,264,792.05 | -74,138,162.11 |
| 利润总额 | 40,557,801.08 | 6,462,781.96 | -77,064,470.19 | -75,201,207.54 |
| 净利润 | 30,959,000.57 | 4,575,834.31 | -84,680,814.44 | -79,128,524.62 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 30,959,000.57 | 4,575,834.31 | -84,680,814.44 | -79,128,524.62 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,268,467,627.63 | 1,251,073,327.06 | 1,284,533,565.21 | 1,189,810,971.39 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,686,348,914.68 | 1,680,574,331.43 | 1,671,105,992.02 | 1,676,268,111.03 |
| 资产总计 | 2,954,816,542.31 | 2,931,647,658.49 | 2,955,639,557.23 | 2,866,079,082.42 |
| 流动负债: | | | | |
| 流动负债合计 | 1,004,798,412.93 | 984,783,019.12 | 1,005,875,981.12 | 982,739,178.19 |
| 非流动负债: | | | | |
| 非流动负债合计 | 154,115,254.76 | 145,598,712.48 | 153,073,483.53 | 82,097,521.83 |
| 负债合计 | 1,158,913,667.69 | 1,130,381,731.6 | 1,158,949,464.65 | 1,064,836,700.02 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,761,459,787.3 | 1,765,796,581.16 | 1,762,180,008.02 | 1,766,097,218.21 |
| 股东权益合计 | 1,795,902,874.62 | 1,801,265,926.89 | 1,796,690,092.58 | 1,801,242,382.4 |
| 负债和股东权益合计 | 2,954,816,542.31 | 2,931,647,658.49 | 2,955,639,557.23 | 2,866,079,082.42 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 482,456,723.35 | 221,520,857.42 | 679,273,627.46 | 553,336,844.67 |
| 经营活动现金流出小计 | 361,724,181.72 | 190,773,877.28 | 520,743,400.29 | 475,527,621.85 |
| 经营活动产生的现金流量净额 | 120,732,541.63 | 30,746,980.14 | 158,530,227.17 | 77,809,222.82 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 4,232,996.28 | 489,000 | 4,171,649.22 | 10,522,594.81 |
| 投资活动现金流出小计 | 36,757,109.87 | 30,686,397.27 | 82,651,345.48 | 37,956,932.98 |
| 投资活动产生的现金流量净额 | -32,524,113.59 | -30,197,397.27 | -78,479,696.26 | -27,434,338.17 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 358,628,507.13 | 215,628,507.13 | 800,051,730 | 490,454,272.3 |
| 筹资活动现金流出小计 | 492,369,585.94 | 261,254,586.81 | 770,988,162.94 | 512,027,831.74 |
| 筹资活动产生的现金流量净额 | -133,741,078.81 | -45,626,079.68 | 29,063,567.06 | -21,573,559.44 |
| 汇率变动对现金及现金等价物的影响 | -25,718.75 | -1,083,969.1 | -1,332,678.06 | -1,001,376.16 |
| 现金及现金等价物净增加额 | -45,558,369.52 | -46,160,465.91 | 107,781,419.91 | 27,799,949.05 |
| 期末现金及现金等价物余额 | 217,712,771.41 | 217,110,675.02 | 263,271,140.93 | 183,289,670.07 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -45,558,369.52 | - | 107,781,419.91 | - |